FDF CDMO

MAXIPLUS MEDICAL & PHARMACEUTICAL offers an integrated development and manufacturing CDMO service

CDMO Service

Through 70 years of experience and knowhow, Maxiplus initiated CDMO service specializing
in oral solids and sustained release depot injection
Based on our successful experience in commercializing Depot injection, and utilizing our 3 Global
R&D centers and 7 Manufacturing sites, Maxiplus will serve a total solution for your outsourcing needs

Service Range
	Type	Platform technology
Product Development Commercial Manufacturing Regulatory Support	Oral Dosage forms	Conventional		Capsule, Tablet (Simple Matrix SR)
		Specialized technology	Modified Release	Tab-in-Tab Double Layered tablet Multi-filling capsule (Mini tablet) MUPS (Multiple Unit Pellet System)
			BA Enhancement	Nano-Crystal
			Compliance Enhancement	Oral dispersible tablet Chewable tablet
	Depot injection	Technology	Spray-drying, Emulsion, Nano-suspension, Nanotube
	Depot injection	Device	Dual Chamber Syringe